AN2 Therapeutics Inc (ANTX)
2.56
+0.02
(+0.79%)
USD |
NASDAQ |
May 03, 16:00
2.55
-0.01
(-0.39%)
After-Hours: 20:00
AN2 Therapeutics Market Cap: 76.36M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 76.36M |
| May 02, 2024 | 75.77M |
| May 01, 2024 | 71.59M |
| April 30, 2024 | 71.59M |
| April 29, 2024 | 70.69M |
| April 26, 2024 | 69.20M |
| April 25, 2024 | 68.01M |
| April 24, 2024 | 71.59M |
| April 23, 2024 | 70.69M |
| April 22, 2024 | 70.26M |
| April 19, 2024 | 73.53M |
| April 18, 2024 | 70.85M |
| April 17, 2024 | 73.83M |
| April 16, 2024 | 73.53M |
| April 15, 2024 | 74.43M |
| April 12, 2024 | 81.57M |
| April 11, 2024 | 89.31M |
| April 10, 2024 | 90.50M |
| April 09, 2024 | 90.80M |
| April 08, 2024 | 89.61M |
| April 05, 2024 | 89.61M |
| April 04, 2024 | 96.75M |
| April 03, 2024 | 100.33M |
| April 02, 2024 | 101.22M |
| April 01, 2024 | 111.94M |
| Date | Value |
|---|---|
| March 28, 2024 | 96.75M |
| March 27, 2024 | 95.86M |
| March 26, 2024 | 92.88M |
| March 25, 2024 | 95.56M |
| March 22, 2024 | 99.14M |
| March 21, 2024 | 98.54M |
| March 20, 2024 | 95.56M |
| March 19, 2024 | 91.40M |
| March 18, 2024 | 87.82M |
| March 15, 2024 | 89.31M |
| March 14, 2024 | 90.41M |
| March 13, 2024 | 88.63M |
| March 12, 2024 | 86.25M |
| March 11, 2024 | 87.74M |
| March 08, 2024 | 87.14M |
| March 07, 2024 | 87.44M |
| March 06, 2024 | 85.36M |
| March 05, 2024 | 83.87M |
| March 04, 2024 | 82.68M |
| March 01, 2024 | 89.22M |
| February 29, 2024 | 88.63M |
| February 28, 2024 | 89.82M |
| February 27, 2024 | 88.63M |
| February 26, 2024 | 93.09M |
| February 23, 2024 | 91.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
68.01M
Minimum
Apr 25 2024
640.33M
Maximum
Jan 09 2024
268.25M
Average
205.67M
Median
Market Cap Benchmarks
| Gilead Sciences Inc | 80.78B |
| QuidelOrtho Corp | 2.841B |
| CymaBay Therapeutics Inc (DELISTED) | -- |
| Insmed Inc | 3.794B |
| Revance Therapeutics Inc | 411.65M |
Market Cap Related Metrics
| Price to Book Value | 0.6124 |
| Price | 2.56 |
| Earnings Yield | -110.2% |